LS
GILD icon

Leelyn Smith’s Gilead Sciences GILD Stock Holding History

Leelyn Smith’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-700
Closed -$60.1K – 231
2022
Q4 		$60.1K Buy
700
+585
+509% +$46.3K 0.02% 163
2022
Q3 		$7K Sell
115
-1,245
-92% -$78.5K ﹤0.01% 334
2022
Q2 		$84K Buy
1,360
+1,355
+27,100% +$83.9K 0.02% 169
2022
Q1 		$0 Hold
5
– – ﹤0.01% 375
2021
Q4 		$0 Hold
5
– – ﹤0.01% 398
2021
Q3 		$0 Hold
5
– – ﹤0.01% 367
2021
Q2 		$0 Sell
5
-74
-94% -$4.94K ﹤0.01% 357
2021
Q1 		$5K Hold
79
– – ﹤0.01% 331
2020
Q4 		$5K Hold
79
– – ﹤0.01% 312
2020
Q3 		$5K Buy
+79
New +$5.48K ﹤0.01% 297
2020
Q2 		– Sell
-5
Closed – – 408
2020
Q1 		$0 Hold
5
– – ﹤0.01% 334
2019
Q4 		$0 Buy
+5
New +$326 ﹤0.01% 316

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leelyn Smith's GILD Position: Q1 2023 in Review

Leelyn Smith sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 700 shares — an estimated $60.1K sold.

Leelyn Smith first reported a position in GILD in Q4 2019 and held it in 12 quarters. The position peaked at $84K in Q2 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Leelyn Smith reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 700 Gilead Sciences shares in Q1 2023, an estimated $60.1K.
  • Leelyn Smith first reported a position in Gilead Sciences in Q4 2019 and held it in 12 quarters.
  • Leelyn Smith's Gilead Sciences position peaked at $84K in Q2 2022.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.